Windlas Biotech Limited (NSE:WINDLAS)
India flag India · Delayed Price · Currency is INR
1,020.00
+21.65 (2.17%)
Nov 12, 2026, 3:30 PM IST

Windlas Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
9,9269,0417,5996,3105,1314,659
Revenue Growth
19.56%18.98%20.43%22.97%10.12%8.96%
Gross Profit
3,8293,4282,8512,3051,8351,581
Operating Income
841.84739.99664.94647.28478.7402.76
Net Income
666.97664.56609.94581.87426.26380.89
Earnings Per Share
31.2731.1528.8727.8819.7018.58
EPS Growth
-1.47%7.90%3.55%41.52%6.03%113.68%

Revenue by Geography

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
India
8,5197,2256,0154,9074,424
outside India
458.38326.32273.91198.43209.35
Total
8,9777,5516,2895,1064,634

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2,6222,7882,3932,0441,3201,760
Total Debt
534.29352.42325.9736.4149.9366.37
Net Cash (Debt)
2,0882,4362,0672,0071,2701,694
Net Cash Growth
-8.96%17.85%2.97%58.08%-25.04%673.25%
Net Cash Per Share
97.90114.1797.8296.1658.6982.64

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
1,0251,049681.871,090609.6591.3
Capital Expenditures
-580.87-676.64-521.94-376.84-708.9-148.04
Free Cash Flow
444.02372.7159.93712.76-99.25-56.74
Free Cash Flow Growth
0.92%133.04%-77.56%---

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
38.58%37.92%37.52%36.54%35.77%33.92%
Operating Margin
8.48%8.19%8.75%10.26%9.33%8.64%
Pretax Margin
8.70%9.62%10.50%12.22%11.12%9.78%
Profit Margin
6.72%7.35%8.03%9.22%8.31%8.18%
FCF Margin
4.47%4.12%2.10%11.30%-1.93%-1.22%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
6.3006.3005.8005.5004.0003.500
Dividend Per Share Growth
8.62%8.62%5.46%37.50%14.29%-
Dividend Yield
0.62%0.86%0.56%1.08%1.78%1.67%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
32.6223.3735.6518.2411.0612.02
P/FCF Ratio
46.9241.67135.9814.89--
PS Ratio
2.101.722.861.680.920.98